Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized, Parallel Group, Non-inferiority, Open-label Study Aiming at Comparing the Healing Rates (With Blinded Assessment Based on Photographs) of TULLEGRAS M.S.® With URGOTUL® in the Treatment of Surgical Acute Wounds.

NCT02322710 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.

NCT NCT02322710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02322710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized, Parallel Group, Non-inferiority, Open-label Study Aiming at Comparing the Healing Rates (With Blinded Assessment Based on Photographs) of TULLEGRAS M.S.® With URGOTUL® in the Treatment of Surgical Acute Wounds.
Lead sponsor
Mylan Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2014
Completion date
November 30, 2016
Enrollment
208 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

surgical acute wounds